Cardinal Health (NYSE:CAH) Price Target Raised to $248.00

Cardinal Health (NYSE:CAH) had its target price raised by Argus from $232.00 to $248.00 in a report published on Wednesday morning,MarketScreener reports. Argus currently has a buy rating on the stock.

A number of other research firms have also commented on CAH. TD Cowen lifted their target price on Cardinal Health from $233.00 to $251.00 and gave the stock a “buy” rating in a report on Wednesday. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $190.00 to $244.00 in a report on Friday, January 9th. Evercore ISI upped their target price on shares of Cardinal Health from $250.00 to $260.00 in a research note on Friday, February 6th. Barclays assumed coverage on shares of Cardinal Health in a research note on Monday, December 8th. They issued an “overweight” rating and a $243.00 price target for the company. Finally, Wells Fargo & Company increased their price objective on shares of Cardinal Health from $237.00 to $256.00 and gave the company an “overweight” rating in a research report on Tuesday. Fifteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $245.19.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $220.72 on Wednesday. Cardinal Health has a 1 year low of $120.72 and a 1 year high of $230.81. The firm’s 50-day moving average is $208.84 and its 200 day moving average is $182.20. The stock has a market cap of $51.94 billion, a price-to-earnings ratio of 31.76, a PEG ratio of 1.39 and a beta of 0.64.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.31 by $0.32. The business had revenue of $65.63 billion during the quarter, compared to analysts’ expectations of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.93 earnings per share. On average, equities analysts expect that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be given a $0.5107 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 29.35%.

Institutional Investors Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Strategy Asset Managers LLC acquired a new position in Cardinal Health during the 3rd quarter valued at approximately $775,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Cardinal Health by 15.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock valued at $5,938,000 after buying an additional 5,030 shares during the last quarter. Versor Investments LP purchased a new stake in shares of Cardinal Health during the third quarter valued at $2,090,000. Atle Fund Management AB increased its position in shares of Cardinal Health by 13.1% in the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock valued at $4,755,000 after acquiring an additional 3,500 shares during the period. Finally, National Pension Service raised its stake in Cardinal Health by 7.2% in the 3rd quarter. National Pension Service now owns 500,340 shares of the company’s stock worth $78,533,000 after acquiring an additional 33,673 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.